Omega-3 for high triglycerides and inflammation
Part of Heart & circulation, Hormones & metabolism clinical trials.
This trial compares a new phospholipid omega-3 supplement with a regular omega-3 supplement to see which works better for people with mixed dyslipidemia (high cholesterol and triglycerides) and high inflammation markers. It may help lower your triglyceride levels and reduce heart-related risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been told you have mixed dyslipidemia (high cholesterol and triglycerides).
- Your fasting triglycerides are between 135 and 499 mg/dL (a blood test result).
- Your body mass index (BMI) is 27 or higher (you are overweight).
- Your high-sensitivity C-reactive protein (hs-CRP) level is above 2 mg/L (a measure of inflammation).
- You have been taking a stable dose of a statin (cholesterol medication) for at least 8 weeks.
- You are not pregnant or breastfeeding, and you have no allergy to fish or seafood.
- You have not taken omega-3 supplements in the last 8 weeks, and you are not in another clinical trial right now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether two types of omega-3s (EPA and DHA) help improve HDL (good cholesterol) and reduce blood clot risk in people with high triglycerides and low HDL cholesterol.
This trial tests whether two natural supplements, curcumin and astaxanthin, can help lower high triglyceride levels and reduce inflammation. It could be a good fit if you have moderately high triglycerides and are generally healthy.
This study tests if eating foods rich in omega-3 fats (like fish and nuts) can lower your triglycerides and improve cholesterol levels. It may help if you have moderately high triglycerides but no other serious health conditions.
This early-phase trial tests an experimental drug called FXR0906 in healthy adults who have elevated triglycerides (a type of fat in the blood). It aims to see if the drug is safe and how it affects cholesterol and fat levels, which may help prevent heart disease.
This study tests whether omega-3 fatty acids can reduce inflammation and improve immune function in older adults with blockages in blood vessels. If you qualify, you may take a daily pill for several months to see if it helps your body's defenses work better.
This trial tests an investigational medication, MAR001, to see if it can lower high levels of fats in the blood (triglycerides and remnant cholesterol) linked to heart disease. If you have these conditions, this treatment might help reduce your risk.
Hear when a new Mixed Dyslipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.